<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aeolus Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals
    Invest Now

    About Aeolus Pharmaceuticals, Inc.

    Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on developing a platform of compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      Start Engine
    • RAISED AMOUNT
      $18,500,000
    • PRE-MONEY EVAULATION
      $794,000.00
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      John L. McManus
    • FOUNDED
      1994
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Aevi Genomic Medicine, Inc.

    Aevi Genomic Medicine, Inc.

    Aevi Genomic Medicine is focused on translating genetic discoveries into novel the...

    Aevi Genomic Medicine is focused on translating...

    Filing Type:    PU
    Nemaura Medical Inc.

    Nemaura Medical Inc.

    Nemaura Medical (NASDAQ:NMRD) is a medical technology company which has developed ...

    Nemaura Medical (NASDAQ:NMRD) is a medical tech...

    Filing Type:    PU
    Astellas Pharma, Inc.

    Astellas Pharma, Inc.

    Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fiel...

    Astellas Pharma Inc. is a pharmaceutical compan...

    Filing Type:    PU
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    Summit Therapeutics plc

    Summit Therapeutics plc

    Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibi...

    Summit Therapeutics is a leader in antibiotic i...

    Filing Type:    PU
    Paratek Pharmaceuticals, Inc.

    Paratek Pharmaceuticals, Inc.

    Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focu...

    Paratek Pharmaceuticals, Inc. is a commercial-s...

    Filing Type:    PU
    Venomyx, Inc

    Venomyx, Inc

    We're developing Vipax, the world's first portable, shelf-stable, broad-spectrum a...

    We're developing Vipax, the world's first porta...

    Amount Raised:    $290,122.00
    Fundraising Status:    EC
    Filing Type:    CF
    Fulcrum Therapeutics, Inc.

    Fulcrum Therapeutics, Inc.

    We are a clinical-stage biopharmaceutical company focused on improving the lives o...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    BioCryst Pharmaceuticals, Inc.

    BioCryst Pharmaceuticals, Inc.

    BioCryst Pharmaceuticals discovers novel, oral small-molecule medicines that treat...

    BioCryst Pharmaceuticals discovers novel, oral ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.